Loading…
Aarti Pharmalabs (AARTIPHARM)₹921.40−0.89%Pharmaceuticals
Aarti Pharmalabs is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 32.4 against a peer median of 29.9, and ROCE of 11.1% against a peer median of 18.0%, and latest-quarter sales growth of 46.0% against a peer median of 17.1%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Viyash Scientific | 10,379 | 41.0 | 13.0 | 7.4 | 0.17 | 0.0 | 3,432 | 225 | 19.3 | 113.3 | vs AARTIPHARM |
| Blue Jet Healthcare | 10,273 | 40.2 | 26.0 | 19.9 | 0.03 | 0.2 | 946 | 248 | −17.4 | −14.3 | vs AARTIPHARM |
| Symbiotec Pharmalab | 9,997 | 88.5 | 13.0 | 11.7 | 0.34 | 0.0 | 867 | 110 | 7.5 | −53.3 | vs AARTIPHARM |
| Procter & Gamble Health | 9,461 | 26.6 | 83.9 | 61.7 | 0.02 | 2.7 | 1,404 | 326 | 7.4 | 45.3 | vs AARTIPHARM |
| Strides Pharma Science | 9,240 | 15.0 | 18.0 | 20.0 | 0.57 | 0.5 | 4,873 | 573 | 17.1 | 1.6 | vs AARTIPHARM |
| Aarti Pharmalabs | 8,357 | 32.4 | 11.1 | 8.6 | 0.36 | 0.4 | 1,816 | 175 | 46.0 | 153.8 | — |
| Sanofi Consumer Healthcare India | 7,933 | 29.9 | 90.0 | 71.6 | 0.06 | 2.2 | 876 | 240 | 6.9 | 13.2 | vs AARTIPHARM |
| Sanofi India | 7,657 | 23.6 | 58.1 | 43.0 | 0.02 | 3.7 | 1,842 | 327 | 7.9 | 19.9 | vs AARTIPHARM |
| Bliss GVS Pharma | 6,947 | 43.0 | 17.0 | 11.8 | 0.02 | 0.2 | 925 | 135 | 28.1 | 82.7 | vs AARTIPHARM |
| Sun Pharma Advanced Research Company | 6,830 | 4.3 | 164.1 | 278.9 | 0.42 | 0.0 | 1,882 | 1,556 | 299.7 | — | vs AARTIPHARM |
| FDC | 6,425 | 20.6 | 15.0 | 11.3 | 0.01 | 1.3 | 2,173 | 282 | 20.8 | 74.8 | vs AARTIPHARM |
| Peer median | 8,357 | 29.9 | 18.0 | 19.9 | 0.06 | 0.4 | 1,816 | 248 | 17.1 | 32.6 |
Listed companies closest to Aarti Pharmalabs in Pharmaceuticals include Viyash Scientific, Blue Jet Healthcare, Symbiotec Pharmalab, Procter & Gamble Health, Strides Pharma Science, Sanofi Consumer Healthcare India, Sanofi India, Bliss GVS Pharma.
Viyash Scientific, with a market cap of ₹10,379 Cr.
Aarti Pharmalabs trades at a P/E of 32.4; the median of its peer set is 29.9. A P/E above or below the median is a description, not a judgement on value.
Aarti Pharmalabs' return on capital employed is 11.1%, below the peer median of 18.0%.